NCT00028236View on ClinicalTrials.gov

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 10, 2001

Primary Completion Date

July 25, 2011

Study Completion Date

July 25, 2011

Conditions
Severe Combined Immunodeficiency
Interventions
DRUG

Gene-Transduced Autologous CD34+ Stem Cells

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00028236 - Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) | Biotech Hunter | Biotech Hunter